Is the P-value Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?

Basit Öğe Kaydı
dc.authoridkus, tulay/0000-0001-5781-4820
dc.authorwosidkus, tulay/JOZ-3660-2023
dc.contributor.authorKus, Tulay
dc.contributor.authorAktas, Gokmen
dc.contributor.authorCicin, Irfan
dc.date.accessioned2024-06-12T11:20:47Z
dc.date.available2024-06-12T11:20:47Z
dc.date.issued2023
dc.departmentTrakya Üniversitesien_US
dc.description.abstractThis commentary asks if, when determining the target P-value in a clinical study, it is sufficient to evaluate the study as negative or positive based on the target P-value alone, or whether this could lead to illusions.en_US
dc.identifier.doi10.1093/oncolo/oyad145
dc.identifier.issn1083-7159
dc.identifier.issn1549-490X
dc.identifier.pmid37294662en_US
dc.identifier.scopus2-s2.0-85175046999en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1093/oncolo/oyad145
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25777
dc.identifier.wosWOS:001003704600001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofOncologisten_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleIs the P-value Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?en_US
dc.typeEditorialen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu